Article Fact Checked

Medically Reviewed

/ Updated March 9th, 2021

Treatment Options for Follicular Lymphoma

×

NOW
PLAYING
87% of Eligible Patients Skip Lung Cancer Screening, Analysis Finds
NOW
PLAYING
FDA Approves First Targeted Therapy For Lung Cancer Patients With the KRAS Gene Mutation
NOW
PLAYING
New Hope For Early Stage Non-Small Cell Lung Cancer Patients
NOW
PLAYING
NFL Coach Ron Rivera on His Skin Cancer Treatment Path
NOW
PLAYING
5 Lessons to Learn from Cindy McCain's New Memoir
NOW
PLAYING
CAR T-Cell Therapy's Current and Future Success

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

SEE MORE   

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Chemotherapy

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

  • Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
  • Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%

Treatment : Mantle Cell Lymphoma

SEE MORE   

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy

Treatment : Mantle Cell Lymphoma

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.